Converging peripheral blood microRNA profiles in Parkinson's disease and progressive supranuclear palsy
Brain Communications,
Journal Year:
2024,
Volume and Issue:
6(3)
Published: Jan. 1, 2024
Abstract
MicroRNAs
act
via
targeted
suppression
of
messenger
RNA
translation
in
the
DNA–RNA–protein
axis.
The
dysregulation
microRNA(s)
reflects
epigenetic
changes
affecting
cellular
processes
multiple
disorders.
To
understand
complex
effect
dysregulated
microRNAs
linked
to
neurodegeneration,
we
performed
a
cross-sectional
microRNA
expression
analysis
idiopathic
Parkinson's
disease
(n
=
367),
progressive
supranuclear
palsy
35)
and
healthy
controls
416)
from
Luxembourg
Study,
followed
by
prediction
modelling,
enriched
pathway
target
simulation
using
probabilistic
Boolean
modelling.
Forty-six
were
identified
be
versus
16
with
4
overlapping
significantly
between
comparisons.
Predictive
power
subsets
(including
up
100
microRNAs)
was
modest
for
differentiating
or
(maximal
cross-validated
area
under
receiver
operating
characteristic
curve
0.76
0.86,
respectively)
low
0.63).
revealed
natural
killer
cell
both,
controls,
indicating
that
immune
system
might
play
an
important
role
both
diseases.
Probabilistic
modelling
dynamics
affected
partially
activity
transcription
factor
EB,
endoplasmic
reticulum
stress
signalling,
calcium
signalling
pathway,
dopaminergic
peroxisome
proliferator-activated
receptor
gamma
coactivator-1α
activity,
though
involving
different
mechanisms.
These
findings
indicated
convergent
(sub)cellular
end-point
dysfunction
at
levels
palsy,
but
distinctive
underlying
molecular
Language: Английский
Neural Excitatory/Inhibitory Imbalance in Motor Aging: From Genetic Mechanisms to Therapeutic Challenges
Biology,
Journal Year:
2025,
Volume and Issue:
14(3), P. 272 - 272
Published: March 7, 2025
Neural
excitatory/inhibitory
(E/I)
imbalance
plays
a
pivotal
role
in
the
aging
process.
However,
despite
its
significant
impact,
of
E/I
motor
dysfunction
and
neurodegenerative
diseases
has
not
received
sufficient
attention.
This
review
explores
mechanisms
underlying
through
lens
balance,
emphasizing
genetic
molecular
factors
that
contribute
to
this
(such
as
SCN2A,
CACNA1C,
GABRB3,
GRIN2A,
SYT,
BDNF…).
Key
regulatory
genes,
including
REST,
vps-34,
STXBP1,
are
examined
for
their
roles
modulating
synaptic
activity
neuronal
function
during
aging.
With
insights
drawn
from
ALS,
we
discuss
how
disruptions
balance
pathophysiology
age-related
dysfunction.
The
genes
discussed
above
exhibit
certain
association
with
neuron
(like
ALS),
relationship
had
been
previously
recognized.
Innovative
therapies,
such
gene
editing
technology
optogenetic
manipulation,
emerging
promising
tools
restoring
offering
hope
ameliorating
deficits
potential
these
technologies
intervene
aging-related
diseases,
challenges
direct
application
human
conditions.
Language: Английский
Recent advances in the molecular signaling pathways of Substance P in Alzheimer's disease: Link to neuroinflammation associated with toll-like receptors
Biochemical and Biophysical Research Communications,
Journal Year:
2024,
Volume and Issue:
733, P. 150597 - 150597
Published: Aug. 23, 2024
A
significant
quantity
of
substance
P
(SP)
and
its
receptor,
the
neurokinin
1
(NK1)
receptors
are
found
in
brain.
SP
is
a
neuropeptide
distributed
central
nervous
system
functions
as
neurotransmitter,
neuromodulator,
neurotrophic
factor.
The
concentrations
brain
cerebrospinal
fluid
fluctuate
individuals
with
Alzheimer's
disease
(AD).
an
endogenous
ligand
for
NK1
enhancing
expression
toll-like
(TLR)
vice
versa.
So,
both
pathways
interconnected,
where
activation
one
pathway
activates
second
pathway.
Researchers
have
observed
interaction
TLR
pathophysiology
AD.
Thus,
this
review
discusses
various
TLRs
involved
regulating
amyloid
processing
Further,
AD
pathology,
can
regulate
non-amyloidogenic
Recent
studies
also
demonstrated
capacity
voltage-gated
potassium
channel
currents,
emphasizing
SP's
neuroprotective
ability.
Therefore,
we
corroborate
findings
linking
SP,
NK1R,
Language: Английский
The GGCT and REST positive feedback loop promotes tumor growth in Glioma
Shang-Hang Shen,
No information about this author
Sifang Chen,
No information about this author
Guo JianFeng
No information about this author
et al.
Translational Oncology,
Journal Year:
2024,
Volume and Issue:
49, P. 102083 - 102083
Published: Aug. 10, 2024
γ-Glutamylcyclotransferase
(GGCT),
an
enzyme
crucial
in
glutathione
metabolism,
has
emerged
as
a
participant
tumorigenesis.
The
present
study
is
designed
to
elucidate
the
biological
role
and
molecular
mechanisms
underlying
GGCT
glioma.
Language: Английский